ICD-10-CM Billable Code

D72.822

Plasmacytosis

Clinical Classification Guidelines

Medical Intelligence & Overview

Plasmacytosis is a medical condition characterized by an abnormal increase in plasma cells within the blood or tissues. Plasma cells are a type of white blood cell crucial for producing antibodies to fight infections. While in some cases plasmacytosis may be a benign response to an infection or inflammation, it can also be associated with more serious medical conditions. This guide provides an overview of plasmacytosis, including potential causes, symptoms, how it is diagnosed, and treatment options.

Causes & Symptoms

Clinical Causes: Reactive response to infections such as viral, bacterial, or parasitic illnesses Chronic inflammatory conditions Certain autoimmune diseases Blood disorders, including multiple myeloma or other plasma cell neoplasms Idiopathic cases, where no specific cause is identified

Key Symptoms: General fatigue and weakness Fever and night sweats Unintended weight loss Swelling or lumps in affected areas Persistent infections Enlarged lymph nodes Bone pain or tenderness, particularly in severe cases Anemia-related symptoms such as pallor and shortness of breath

Diagnostic & Treatment

Diagnosis Path: The diagnosis of plasmacytosis involves a combination of blood tests, imaging studies, and sometimes tissue biopsies. Key diagnostic steps include: - Blood count tests revealing increased plasma cells - Serum protein electrophoresis to detect abnormal antibody proteins - Bone marrow biopsy to assess plasma cell infiltration - Imaging studies such as X-rays or MRI to evaluate organ involvement - Additional tests to rule out underlying conditions like infections or neoplasms Early detection and comprehensive testing are essential for determining the underlying cause and appropriate management.

Treatment Protocols: Treatment strategies depend on the underlying cause and severity of plasmacytosis. Common approaches include: - Addressing underlying infections with appropriate medications - Managing autoimmune conditions with immunosuppressive therapies - Monitoring mild cases without immediate treatment - Chemotherapy or targeted therapies in cases associated with plasma cell neoplasms - Regular follow-ups to track disease progression or response to therapy Since plasmacytosis can be a manifestation of various health issues, individualized care plans are typically developed by healthcare providers based on specific patient needs.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is D72.822 a billable ICD-10 code?
Yes, D72.822 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report D72.822?
Clinical documentation must specify the nature of Plasmacytosis and any associated comorbidities for accurate reporting.

Cite this Clinical Reference